Ireland-based Covidien has launched its Symbotex composite mesh in the US for surgical laparoscopic and open ventral hernia repair.
Symbotex composite mesh features a macroporous monofilament, hydrophilic textile in a 3D construction that allows for reinforced strength, memory shape and significant tissue ingrowth. It includes a bioabsorbable collagen film on the visceral side which minimizes tissue attachments.
The new hernia repair product has an orientation marker, which facilitates correctly placing the mesh over the hernia defect. According to Covidien, this product allows surgeons to perform surgical laparoscopic and open ventral hernia repairs in an easier way.
The Symbotex mesh, which is transparent, offers improvements to the visualization of the anatomy during mesh placement and fixation. Symbotex mesh is available in a large variety of shapes and sizes for laparoscopic hernia repair, with specific subranges dedicated to laparoscopic and open surgery.
Covidien Hernia Care vice president and general manager Rob Claypoole noted through ongoing collaboration with the company’s customers it knows there is a need for a mesh that is easy to use and provides optimal repair for patients and it believes Symbotex provides the best of both worlds.
"With the addition of Symbotex, our hernia product line offers surgeons an even broader choice of unique solutions to address diverse patient needs," Claypoole added.
In August 2013, Covidien obtained 510(k) approval from the US Food and Drug Administration for its Symbotex composite mesh.
Covidien has announced the US launch of the new product at the American Hernia Society’s 16th Annual Hernia Repair meeting, taking place in Las Vegas, Nevada.
In addition to Symbotex composite mesh, the company is showcasing the latest innovations to its portfolio of hernia repair products, which includes AccuMesh positioning system and ProGrip laparoscopic self-fixating mesh.
Image: Covidien’s Symbotex composite mesh for surgical laparoscopic and open ventral hernia repair. Photo: Courtesy of BusinessWire/Covidien plc